Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Moderna's new version of its COVID-19 vaccine ... who added that the new vaccine also seems to achieve a more durable response than Moderna's first bivalent shot mRNA-1273.211, based on the ...

Argentina's Health Ministry Carla Vizzotti insisted that people needed to get an additional shot of Covid-19 vaccine ... the country would have bivalent vaccines available in the first quarter ...

US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years ...